Evidence map›Paper›PMID 24986547›Full record

ArticlePigment cell & melanoma research2014

DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.

Nancy E Thomas, Nathaniel A Slater, Sharon N Edmiston, Xin Zhou, Pei-Fen Kuan, Pamela A Groben, Craig C Carson, Honglin Hao, Eloise Parrish, Stergios J Moschos and 3 more

Abstract read
In one paragraph

Article in Pigment cell & melanoma research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Rapidly Evolving Pre- and Post-surgical Systemic Treatment of Melanoma.American journal of clinical dermatology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  11. Article
  12. Epigenetic markers in melanoma.Melanoma management · 2015
    Review
  13. Article
  14. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Nancy E ThomasDepartment of Dermatology, University of North Carolina, Chapel Hill, NC, USA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Nathaniel A Slater
Sharon N Edmiston
Xin Zhou
Pei-Fen Kuan
Pamela A Groben
Craig C Carson
Honglin Hao
Eloise Parrish
Stergios J Moschos
Marianne Berwick
David W Ollila
Kathleen Conway
University of North Carolina at Chapel Hill · USUNC Lineberger Comprehensive Cancer CenterUniversity of New Mexico · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
UNC Clinical and Translational Science AwardUL1TR000083 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2012 to 2013
$11.6M
Melanoma RAS/BRAF Mutation:Heterogeneity-Risk-PrognosisR01CA112243 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMAS, NANCY E. · 2005 to 2014
$5.4M
High-Throughput DNA-Methylation Profiling from Fixed Melanocytic TissuesR33CA160138 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DORSEY, KATHLEEN CONWAY, THOMAS, NANCY E. · 2011 to 2013
$979k
DNA-Methylation Profiling from Fixed Melanocytic TissuesR21CA134368 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DORSEY, KATHLEEN CONWAY, THOMAS, NANCY E. · 2009 to 2010
$356k
NCATS NIH HHS UL1 TR000083NCATS NIH HHS UL1 TR001111NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA112243NCI NIH HHS R01CA112243NCI NIH HHS R21 CA134368NCI NIH HHS R33 CA160138NIEHS NIH HHS P30 ES010126PHS HHS ULTR000083
6 · The paper itself

Abstract

DNA methylation studies have elucidated a methylation signature distinguishing primary melanomas from benign nevi and provided new insights about genes that may be important in melanoma development. However, it is unclear whether methylation differences among primary melanomas are related to tumor pathologic features with known clinical significance. We utilized the Illumina GoldenGate Cancer Panel array to investigate the methylation profiles of 47 primary cutaneous melanomas. Arraywide methylation patterns revealed a positive association of methylation with Breslow thickness and mutated BRAF, a negative association with mitotic rate, and a weak association with ulceration. Hierarchical clustering on CpG sites exhibiting the most variable methylation (n = 235) divided the melanoma samples into three clusters, including a highly methylated cluster that was positively associated with Breslow thickness and an intermediately methylated cluster associated with Breslow thickness and mitotic rate. Our findings provide support for the existence of methylation-defined subsets in melanomas with increased methylation associated with Breslow thickness.

Indexed as

AdultAgedCluster AnalysisCpG IslandsCutaneous Malignant MelanomaDemographyDNA MethylationFemaleGenetic LociHumansMaleMelanomaMiddle AgedMolecular Sequence DataPhenotypePromoter Regions, GeneticCpG island methylator phenotypeglobal methylation patternsmelanomamethylationmethylation clusters or subgroupspathologic featuresprimary melanoma

Identifiers

PMID24986547
PMCPMC4211983
OpenAlexW2164905024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.